IRONWOOD PHARMACEUTICALS, INC.

Analyst Reco. Ironwood Pharmaceuticals, Inc.

Equities

IRWD

US46333X1081

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-28 pm EDT			5-day change	1st Jan Change
5.88 ^USD	-1.18%		-13.27%	-48.60%

May. 22	Ironwood Pharmaceuticals Insider Sold Shares Worth $436,136, According to a Recent SEC Filing	MT
May. 21	Ironwood Pharmaceuticals, Inc. Presents Late-Breaking Data During the 2024 Digestive Disease Week Meeting from Its Pivotal Phase III Clinical Trial, STARS	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ironwood Pharmaceuticals Insider Sold Shares Worth $436,136, According to a Recent SEC Filing	May. 22	MT
Piper Sandler Adjusts Price Target on Ironwood Pharmaceuticals to $21 From $20, Maintains Overweight Rating	Feb. 16	MT
Craig-Hallum Starts Coverage on Ironwood Pharmaceuticals with Buy Rating, $21 Price Target	Jan. 17	MT
JMP Securities Starts Ironwood Pharmaceuticals at Market Outperform, $22 Price Target	23-09-28	MT
Piper Sandler Adjusts Price Target on Ironwood Pharmaceuticals to $19 From $16, Maintains Overweight Rating	23-05-23	MT
Capital One Securities Initiates IRWD at Overweight with $15 Price Target	22-09-02	MT
Wells Fargo Adjusts Ironwood Pharmaceuticals' Price Target to $13 from $12, Maintains Equalweight Rating	22-08-16	MT
Piper Sandler Starts Ironwood Pharmaceuticals at Overweight With $16 Price Target	22-04-22	MT
IRONWOOD PHARMACEUTICALS : Morgan Stanley Adjusts Price Target on Ironwood Pharmaceuticals to $14 From $13, Maintains Equal-Weight Rating	21-10-12	MT
IRONWOOD PHARMACEUTICALS : Morgan Stanley Adjusts Price Target on Ironwood Pharmaceuticals to $12 From $11, Maintains Equal-Weight Rating	21-07-16	MT
IRONWOOD PHARMACEUTICALS : Morgan Stanley Adjusts Ironwood Pharmaceuticals' Price Target to $12 from $11, Keeps Equalweight Rating	20-11-06	MT
IRONWOOD PHARMACEUTICALS : Credit Suisse Adjusts Ironwood Pharmaceuticals' Price Target to $12 From $11, Maintains Neutral Rating	20-11-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer